clomipramine has been researched along with Dizziness in 4 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Dizziness: An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Using data from Ciba-Geigy's multicenter 10-week clinical trial, we studied the relationship between early side effects and subsequent therapeutic response to clomipramine (CMI) in obsessive-compulsive disorder." | 9.08 | Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive-compulsive disorder. ( Ackerman, DL; Bystritsky, A; Greenland, S; Katz, RJ, 1996) |
| " Using data from Ciba-Geigy's multicenter 10-week clinical trial, we studied the relationship between early side effects and subsequent therapeutic response to clomipramine (CMI) in obsessive-compulsive disorder." | 5.08 | Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive-compulsive disorder. ( Ackerman, DL; Bystritsky, A; Greenland, S; Katz, RJ, 1996) |
| " Thirty-eight patients with episodic, chronic and atypical depressive disorder (DSM-III) were equally randomized to 6 weeks' treatment with either three daily doses of 100 mg moclobemide or 50 mg clomipramine." | 5.05 | Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial. ( Holm, P; Larsen, JK; Mikkelsen, PL, 1984) |
| "We studied reported withdrawal symptoms in a retrospective chart review of 352 patients treated in an outpatient clinic with the nonselective serotonin reuptake inhibitor clomipramine or with one of the selective serotonin reuptake inhibitors (SSRIs), fluoxetine, fluvoxamine, paroxetine, or sertraline." | 1.29 | Serotonin reuptake inhibitor withdrawal. ( Bell, CJ; Coupland, NJ; Potokar, JP, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larsen, JK | 1 |
| Holm, P | 1 |
| Mikkelsen, PL | 1 |
| Ackerman, DL | 1 |
| Greenland, S | 1 |
| Bystritsky, A | 1 |
| Katz, RJ | 1 |
| Coupland, NJ | 1 |
| Bell, CJ | 1 |
| Potokar, JP | 1 |
| Skjelbo, EF | 1 |
| Brøsen, K | 1 |
2 trials available for clomipramine and Dizziness
| Article | Year |
|---|---|
Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
Topics: Adult; Aged; Benzamides; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dizziness; Dou | 1984 |
Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Constipation; Dizziness; Humans; Male; Obsessive-Compulsive Disorder; Selective | 1996 |
2 other studies available for clomipramine and Dizziness
| Article | Year |
|---|---|
Serotonin reuptake inhibitor withdrawal.
Topics: 1-Naphthylamine; Adolescent; Adult; Age Factors; Clomipramine; Dizziness; Female; Fluvoxamine; Human | 1996 |
[Interaction between paroxetine and clomipramine as a possible reason for admission to a department of internal medicine].
Topics: Aged; Antidepressive Agents, Tricyclic; Clomipramine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2 | 1998 |